I am inclined to feel the same way here Alan. The company has a long runway ahead of it, and if one has a mid-range view, I believe you will make some very good profits at this entry point.
- Forums
- ASX - By Stock
- NXL
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-11
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.40 |
Change
-0.100(2.86%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.809M | 820.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2881 | $3.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.42 | 3213 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 97 | 3.390 |
1 | 1541 | 3.380 |
1 | 2881 | 3.360 |
1 | 2881 | 3.350 |
1 | 2881 | 3.340 |
Price($) | Vol. | No. |
---|---|---|
3.400 | 72143 | 4 |
3.410 | 4033 | 2 |
3.420 | 3213 | 2 |
3.430 | 2881 | 1 |
3.440 | 2881 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online